Clinical Trials Insight: 700019429
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 May 2008
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 08 May 2008 Data from this study will be presented at ASCO 2008, according to YM Biosciences.
- 04 Dec 2006 New trial record.